Skip to content

A single-centre randomised controlled trial of ultra low dose radiotherapy for ocular adnexal MALT lymphoma and follicular lymphoma

4 Gy versus 24 Gy radiotherapy for patients with ocular indolent lymphoma: a randomised non-inferiority trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035488
Enrollment
Unknown
Registered
2020-08-12
Start date
2020-08-14
Completion date
Unknown
Last updated
2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ocular indolent non-Hodgkin lymphoma

Interventions

1:ultra low-dose radiation group
2:regular dose radiation group

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients aged >=18 years; 2. Patients with stage I-II ocular MALT or follicular lymphoma involving the conjunctiva, lacrimal gland, oribt soft tissue, extraocular muscle or choroid; 3. Histologically proven follicular or MALT non-Hodgkin's lymphoma; 4. Radiation indicated for definitive treatment of stage I or II disease or for palliation after surgery; 5. Female patients of childbearing potential must have a negative serum pregnancy test (human chorionic gonadotropin [hCG]) within 2 weeks of protocol entry; 6. Written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with stage III-IV non-Hodgkin's lymphoma; 2. Patients with aggressive B cell lymphoma histology, including diffuse large B cell lymphoma (DLBCL) and mantle cell lymphoma; 3. Patients with severe anemia or mental disorder; 4. Patients who are pregnant.

Design outcomes

Primary

MeasureTime frame
Local progression free rate;

Secondary

MeasureTime frame
efficacy;overall survival;

Countries

China

Contacts

Public ContactXiaolu Yang

Shanghai General Hospital

dryangxiaolu@163.com+86 15317314398

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026